skip to primary navigationskip to content

Stem Cells, Big Data & Personalised Medicine

A public discussion @ the Cambridge Science Festival

2016 03 scifest talk full 9The concept of personalised medicine understandably attracts a lot of attention. Genomics enable us to better stratify patients into specific treatment groups based on their genetic make-up and risk factors. Equally, stem cells offer the ability to test drugs and therapies on copies of a patient's own cells. Lots of progress is being made in this area but how much data is involved, who has access to it and how is it protected?

These were the key issues that our diverse panel of experts 2016 03 scifest talk 2attempted to tackle during out 'Stem Cells, Big Data & Personalised Medicine' event. Our speakers were: Dr Maria Alcolea, Dr Paul Bertoni, Dr Nicolas Le Novere, Dr Chris Kirton & Dr Minal Patel.

A key objective of the event was to be responsive to what the audience wanted to hear about so we had lots of opportunities to comment, ask questions and change the direction of the discussion. This made for a very lively and vibrant conversation that covered a very broad range of topics. This event was co-hosted by four leading bio-medical research institutes: Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute; Wellcome Trust Sanger Institute; Wellcome Trust / Cancer Research UK Gurdon Institute; and The Babraham Institute.

RSS Feed Latest news

Stem Cell Institute Group Leaders elected as EMBO members

Jul 07, 2020

Two Cambridge Stem Cell Institute Group Leaders are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Institute PIs awarded university promotions

Jun 26, 2020

Many congratulations to our institute and affiliate PIs who have been awarded promotions through the University’s Academic Promotions process recognising their outstanding work.

Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds

May 18, 2020

The expansion of ‘mutant’ cells that could lead to cancer is often kept in check by their neighbours, research from the Wellcome Sanger Institute, the University of Cambridge and their collaborators has found. The team discovered that when equally-matched cells in the oesophagus of mice coincided, they acted as a brake on one another’s growth.

Professor Ludovic Vallier elected to the Fellowship of the Academy of Medical Sciences

May 13, 2020

The Academy of Medical Sciences has elected 50 of the UK’s most prominent biomedical and health scientists to their Fellowship.

Key nose cells identified as likely COVID-19 virus entry points

Apr 23, 2020

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

The Institute is funded by Wellcome and the Medical Research Council.

         

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.